These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17095130)

  • 1. Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life.
    van der Sande MA; Mendy M; Waight P; Doherty C; McConkey SJ; Hall AJ; Whittle HC
    Vaccine; 2007 Feb; 25(8):1509-12. PubMed ID: 17095130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
    van der Sande MA; Waight PA; Mendy M; Zaman S; Kaye S; Sam O; Kahn A; Jeffries D; Akum AA; Hall AJ; Bah E; McConkey SJ; Hainaut P; Whittle HC
    PLoS One; 2007 Aug; 2(8):e753. PubMed ID: 17710152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD005530. PubMed ID: 22513932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Schwarz TF; Behre U; Adelt T; Donner M; Suryakiran PV; Janssens W; Mesaros N; Panzer F
    Hum Vaccin Immunother; 2019; 15(1):235-241. PubMed ID: 30118633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up.
    Roznovsky L; Orsagova I; Kloudova A; Tvrdik J; Kabieszova L; Lochman I; Mrazek J; Hozakova L; Zjevikova A; Pliskova L
    Infection; 2010 Oct; 38(5):395-400. PubMed ID: 20589522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children.
    Yuen MF; Lim WL; Chan AO; Wong DK; Sum SS; Lai CL
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):941-5. PubMed ID: 15476159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.
    Sodhi JS; Raja W; Zargar SA; Showkat A; Parveen S; Nisar S; Wani MA; Javid G; Khan M; Aejaz S; Mohd G; Jan A; Yattoo GN; Shah A; Gulzar GM; Lone R
    Indian J Gastroenterol; 2015 Sep; 34(5):372-9. PubMed ID: 26531066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.
    Wu Q; Zhuang GH; Wang XL; Hou TJ; Shah DP; Wei XL; Wang LR; Zhang M
    Hum Vaccin Immunother; 2012 Aug; 8(8):1071-6. PubMed ID: 22854666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity.
    del Canho R; Grosheide PM; Mazel JA; Heijtink RA; Hop WC; Gerards LJ; de Gast GC; Fetter WP; Zwijneberg J; Schalm SW
    Vaccine; 1997 Oct; 15(15):1624-30. PubMed ID: 9364693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.
    Agladioglu S; Beyazova U; Camurdan AD; Sahin F; Atak A
    Infection; 2010 Aug; 38(4):269-73. PubMed ID: 20512395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.